ArticlePloS one2025
From CBC to clarity: Interpretable detection of beta-thalassemia carriers in imbalanced datasets.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thalassemia is an inherited blood disorder and is among the five most prevalent birth-related complications, especially in Southeast Asia. Thalassemia is classified into two main types-alpha-thalassemia and beta-thalassemia-based on the reduced or absent production of the corresponding globin chains. Over the past couple of decades, researchers have increasingly focused on the application of machine learning algorithms to medical data for identifying hidden patterns to assist in the prediction and classification of diseases and patients. To effectively analyze more complex medical data, more robust machine learning models have been developed to address various health issues. Many researchers have employed different artificial intelligence-based algorithms, i.e., Random Forest, Decision Tree, Support Vector Machine, ensemble-based classifiers, and deep neural networks to accurately detect carriers of beta-thalassemia by training on both diseased and normal test reports. While genetic testing is required by doctors for the most accurate diagnosis, a simple Complete Blood Count (CBC) report can be used to estimate the likelihood of being a beta-thalassemia carrier. Various models have successfully identified beta-thalassemia carriers using CBC data alone, but these models perform classification and prediction based on normalized data. They achieve high accuracy but at the cost of substantial changes to the dataset through class normalization. In this research, we have proposed a Dominance-based Rough Set Approach model to classify patients without balancing the classes (Normal, Abnormal), and the model achieved good performance (91% accuracy). In terms of generalization, the proposed model obtained 89% accuracy on unseen data, comparable to or better than existing approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.